Ampio Pharma off 5.4% as it prices secondary

|About: Ampio Pharmaceuticals, Inc. (AMPE)|By:, SA News Editor

The 8.5M share secondary offering is priced at $7 per share for gross proceeds of $59.5M, and net proceeds expected to be about $55M. This doesn't include the greenshoe to bookrunners Citi and Jefferies of 1.275M shares.

AMPE -5.4% premarket to $7.51 per share